Search Results

An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.

An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.

In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.

A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.

The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.

A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.

A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.

As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.

With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.

An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.

With the US-Iran peace deal signed and the Strait of Hormuz set to reopen, Ireland's pharmaceutical export sector stands to benefit from stabilized global energy tariffs, normalized maritime trade corridors, and renewed multinational capital inflows.

A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.

The European Commission has proposed the European Biotech Act to turbocharge the EU's health biotechnology sector, streamline regulations, and regain global competitiveness against the US and China.

Ireland’s pharma exports fell 35% in Jan 2026, driven by a sharp decline in US shipments. Explore causes, trends, and global life sciences impact.